BTEK.L vs. IBBQ
Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Invesco Nasdaq Biotechnology ETF (IBBQ).
BTEK.L and IBBQ are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BTEK.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Oct 19, 2017. IBBQ is a passively managed fund by Invesco that tracks the performance of the NASDAQ / Biotechnology. It was launched on Jun 11, 2021. Both BTEK.L and IBBQ are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BTEK.L or IBBQ.
Key characteristics
| BTEK.L | IBBQ | |
|---|---|---|
| YTD Return | 1.02% | 0.89% |
| 1Y Return | 3.42% | 4.03% |
| Sharpe Ratio | 0.35 | 0.32 |
| Daily Std Dev | 15.01% | 16.85% |
| Max Drawdown | -30.86% | -37.94% |
| Current Drawdown | -10.61% | -17.89% |
Correlation
The correlation between BTEK.L and IBBQ is 0.66, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BTEK.L vs. IBBQ - Performance Comparison
In the year-to-date period, BTEK.L achieves a 1.02% return, which is significantly higher than IBBQ's 0.89% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BTEK.L vs. IBBQ - Expense Ratio Comparison
BTEK.L has a 0.35% expense ratio, which is higher than IBBQ's 0.00% expense ratio.
Risk-Adjusted Performance
BTEK.L vs. IBBQ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Invesco Nasdaq Biotechnology ETF (IBBQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BTEK.L vs. IBBQ - Dividend Comparison
BTEK.L has not paid dividends to shareholders, while IBBQ's dividend yield for the trailing twelve months is around 0.83%.
| TTM | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% |
IBBQ Invesco Nasdaq Biotechnology ETF | 0.83% | 0.81% | 0.76% | 0.63% |
Drawdowns
BTEK.L vs. IBBQ - Drawdown Comparison
The maximum BTEK.L drawdown since its inception was -30.86%, smaller than the maximum IBBQ drawdown of -37.94%. Use the drawdown chart below to compare losses from any high point for BTEK.L and IBBQ. For additional features, visit the drawdowns tool.
Volatility
BTEK.L vs. IBBQ - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Invesco Nasdaq Biotechnology ETF (IBBQ) have volatilities of 4.92% and 4.69%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.